Evidence map›Paper›PMID 36350341›Full record

ArticleAnalytical and bioanalytical chemistry2022

Quantitative detection of urinary bladder cancer antigen via peptide-immobilized magnetic bead-based SERS probe.

Yue Hou, Chaoming Yang, Chuanzhi Liu, Le Gao, Zhiyong Ma, Yuanhua Yu, Weigang Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yue HouSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China.
Chaoming YangSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China.
Chuanzhi LiuSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China.
Le GaoSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China.
Zhiyong MaThe No. 2 Depart of Urol., Jilin University First Hospital, Changchun, 130022, China.
Yuanhua YuSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, 130022, China. yuyuanhua8888@126.com.ORCID http://orcid.org/0000-0001-6447-5855
Weigang WangThe No. 2 Depart of Urol., Jilin University First Hospital, Changchun, 130022, China.
Changchun University of Science and Technology · CNJilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibody pairing is a difficult step in developing all immune-sandwich assay for antigen detection. Urinary bladder cancer (UBC) antigen is a typical bladder cancer biomarker for the early diagnosis of bladder cancer. Based on peptide-antibody pairing, a surface-enhanced Raman scattering platform for the ultrasensitive detection of UBC is presented. The phage display tech was used to screen and obtain a 12-peptide ligand against UBC (KD = 4.84 × 10

Indexed as

Metal NanoparticlesUrinary Bladder NeoplasmsAntibodiesGoldHumansLigandsMagnetic FieldsPeptidesSilverSpectrum Analysis, RamanAntibodiesGoldLigandsPeptidesSilverBladder cancerPhage display technologySurface-enhanced Raman scatteringUBC detection

Identifiers

PMID36350341
OpenAlexW4308635979

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.